IT1244489B - Controlled release pharmaceutical composition containing a pharmaceutically acceptable salt of buflomedil - Google Patents

Controlled release pharmaceutical composition containing a pharmaceutically acceptable salt of buflomedil

Info

Publication number
IT1244489B
IT1244489B IT02249390A IT2249390A IT1244489B IT 1244489 B IT1244489 B IT 1244489B IT 02249390 A IT02249390 A IT 02249390A IT 2249390 A IT2249390 A IT 2249390A IT 1244489 B IT1244489 B IT 1244489B
Authority
IT
Italy
Prior art keywords
buflomedil
pharmaceutically acceptable
acceptable salt
pharmaceutical composition
composition containing
Prior art date
Application number
IT02249390A
Other languages
Italian (it)
Other versions
IT9022493A1 (en
IT9022493A0 (en
Inventor
Edoardo Maragliano
Giacomo Assereto
Original Assignee
Vecchi & C Piam Di G Assereto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vecchi & C Piam Di G Assereto filed Critical Vecchi & C Piam Di G Assereto
Priority to IT02249390A priority Critical patent/IT1244489B/en
Publication of IT9022493A0 publication Critical patent/IT9022493A0/en
Publication of IT9022493A1 publication Critical patent/IT9022493A1/en
Application granted granted Critical
Publication of IT1244489B publication Critical patent/IT1244489B/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to a controlled release pharmaceutical composition containing a pharmaceutically acceptable salt of buflomedil, preferably the hydrochloride. This composition, which is based on the use of a hydrophilic matrix to which normal binding agents and lubricants are mixed is obtained by simple wet granulation followed by compression. In this way tablets having the properties of releasing the active ingredient in a controlled way, thus ensuring constant blood levels for 24 hours, can be obtained.
IT02249390A 1990-12-21 1990-12-21 Controlled release pharmaceutical composition containing a pharmaceutically acceptable salt of buflomedil IT1244489B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IT02249390A IT1244489B (en) 1990-12-21 1990-12-21 Controlled release pharmaceutical composition containing a pharmaceutically acceptable salt of buflomedil

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT02249390A IT1244489B (en) 1990-12-21 1990-12-21 Controlled release pharmaceutical composition containing a pharmaceutically acceptable salt of buflomedil

Publications (3)

Publication Number Publication Date
IT9022493A0 IT9022493A0 (en) 1990-12-21
IT9022493A1 IT9022493A1 (en) 1992-06-21
IT1244489B true IT1244489B (en) 1994-07-15

Family

ID=11197011

Family Applications (1)

Application Number Title Priority Date Filing Date
IT02249390A IT1244489B (en) 1990-12-21 1990-12-21 Controlled release pharmaceutical composition containing a pharmaceutically acceptable salt of buflomedil

Country Status (1)

Country Link
IT (1) IT1244489B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102406625A (en) * 2011-11-28 2012-04-11 北京四环科宝制药有限公司 Buflomedil hydrochloride sustained release tablet with high release rate and preparation method thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102406625A (en) * 2011-11-28 2012-04-11 北京四环科宝制药有限公司 Buflomedil hydrochloride sustained release tablet with high release rate and preparation method thereof

Also Published As

Publication number Publication date
IT9022493A1 (en) 1992-06-21
IT9022493A0 (en) 1990-12-21

Similar Documents

Publication Publication Date Title
HK1054196A1 (en) Pharmaceutical formulation containing tolterodine and its use
UA29563C2 (en) Microcapsule for prolonged release of physiologically active peptide
EP0509317A3 (en) Use of droloxifene in the treatment of bone diseases
MX9504034A (en) Medical administering forms containing tioctic acid, or tioctic acid solid salts having improved release and bioavailability.
HK1003978A1 (en) Composition for the treatment of schizophrenia
ATE75945T1 (en) PHARMACEUTICAL PREPARATION FOR TREATMENT OF DIABETES MELLITUS.
ZA9426B (en) Use of riluzole for the treatment of Parkinson's Disease and Parkinsonian Syndromes
SE8804628A (en)
IL84844A0 (en) Pharmaceutical compositions comprising a certain carbazolone derivative or a salt thereof
BG60101A3 (en) Method for preparing of 4-fluoro-2-[[(4-methoxy-2-pyridinyl)methyl]thionil]-1h-benzimidazo le
HUP9802897A3 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
CA2152998A1 (en) Anti-hyperglycemia pharmaceutical composition
IT1244489B (en) Controlled release pharmaceutical composition containing a pharmaceutically acceptable salt of buflomedil
ES476428A1 (en) Pharmaceutical compositions
EP0373771A3 (en) New pharmaceutical uses for cystatins
EP0351876A3 (en) Composition for potentiating vaccination effect
IE873231L (en) Medicaments
PT711163E (en) USE OF BENZIDAMINE IN THE TREATMENT OF TNF-INDUCED PATHOLOGICAL STATES
TW333453B (en) Pharmaceutical composition comprising toremifene for use in the treatment of autoimmune diseases
HU9802896D0 (en) Optically active piperidinoalkyl-4h-1,2,4-oxadiazine derivative, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
KR890000089A (en) Kidney disease treatment
MX9605633A (en) Pharmaceutical composition for preventing or treating dry eye or disease caused therefrom.
GB9005316D0 (en) Pharmaceutical composition comprising 3-(n-piperidinomethyl-azino)methylrifamycin s as active ingredient
IT1246790B (en) Pharmaceutical compositions for the treatment of Parkinson's disease.
SE0000782D0 (en) Pharmaceutical formulation and its use

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971223